Back to List
Fibronostics Secures Financing, Announces New CEO
Fibronostics, a global leader in noninvasive, AI-driven diagnostics for NASH patients, announced it has secured $6.5 million in funding. In addition to the financing, Sven Henrichwark, Ph.D., has been named the company's CEO.
© APSense LTD. All-in-One Business Hub. All Rights Reserved. This forum service is provided by APSense.com
Comments
How it works: